✦ LIBER ✦

Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer

✍ Scribed by Shuya Hirao; Tomoko Hirao; Carmen J. Marsit; Yoko Hirao; Alan Schned; Tara Devi-Ashok; Heather H. Nelson; Angeline Andrew; Margaret R. Karagas; Karl T. Kelsey

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 81 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21423

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Distinct regions of frequent loss of het

Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer

✍ Robert C. Peralta; Alan G. Casson; Rui-nan Wang; Shaf Keshavjee; Mark Redston; B 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 128 KB 👁 2 views

Loss of heterozygosity (LOH) studies reported thus far suggest that tumor suppressor loci on chromosome 5q are important in esophageal cancer (EC) while little is known about the involvement of chromosome 5p. To investigate the potential existence of tumor suppressor gene(s) on chromosome 5 contribu

Loss of heterozygosity on chromosome 9q2

Loss of heterozygosity on chromosome 9q21 (p16 gene) uncommon in soft-tissue sarcomas

✍ Regine Schneider-Stock; Kathrin Radig; Albert Roessner 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

Chromosome region 9p21 contains a tumor suppressor locus (p16) that may be involved in the genesis of several kinds of malignant tumors. To characterize the role of this gene in the development of soft-tissue tumors (STTs), we investigated the frequency of loss of heterozygosity (LOH) at this locus.

Allelotype of uterine cancer by analysis

Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: Frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p

✍ Michael H. Jones; Yusuke Nakamura; Sumiko Koi; Lkuno Fujimoto; Katsuhiko Hasumi; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 1 views

Departments of Biochemistry (M.H.J., Y.N.) and Gynecology (S.K.. I.F., K.H.), Cancer Institute, Tokyo, japan, and SRL Corporation (K.K.), Tokyo, japan Cancers in which mutations have been identified in putative tumor suppressor genes, such as the TP53 gene, the retinoblastoma ( R B I ) gene, the ade

Loss of heterozygosity on chromosome 9 a

Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers

✍ Françoise Muzeau; Jean François Fléjou; Gilles Thomas; Richard Hamelin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

Loss of heterozygosity on chromosome 9 has been reported in a variety of human cancers. The cyclin-dependent kinase inhibitor p16 gene, mapped on chromosome 9p21, is presumed to be the tumor-suppressor gene localized in this chromosome. The aim of our study was to determine, in 26 Barrett's adenocar

Loss of heterozygosity on chromosome 9 a

Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder

✍ Angela A. G. Van Tilborg; Arnold C. P. Hekman; Kees J. Vissers; Theo H. van der 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 106 KB 👁 2 views

The most frequent genetic aberration found in transitional cell carcinoma (TCC) of the bladder involves chromosome 9. Loss of heterozygosity (LOH) analyses show deletions of both chromosome 9p and 9q, while in situ hybridization studies suggest a significant percentage of tumours with monosomy 9. To

Generation of loss of heterozygosity and

Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells

✍ Masamitsu Honma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB 👁 1 views

## Abstract Loss of heterozygosity (LOH) is a critical event in the development of human cancers. LOH is thought to result from either a large deletion or recombination between homologous alleles during repair of DNA double‐strand breaks (DSBs). These types of genetic alterations produce mutations